[Home Inns Reports Third Quarter of 2009 Financial Results Quarterly Revenues Increased 38% Year-over-year to RMB 727 Million (US$ 107 Million); Shanghai, November 9, 2009 Third Quarter 2009 Financial Highlights Total revenues for the quarter increased 37.9% year-over-year to RMB 727.4 million (US$ 106.6 million), exceeding guidance of RMB 685 million to RMB 705 million. Net income]
[Home Inns Reports Third Quarter of 2009 Financial Results Quarterly Revenues Increased 38% Year-over-year to RMB 727 Million (US$ 107 Million); Shanghai, November 9, 2009 Third Quarter 2009 Financial Highlights Total revenues for the quarter increased 37.9% year-over-year to RMB 727.4 million (US$ 106.6 million), exceeding guidance of RMB 685 million to RMB 705 million. Net income]
[] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321093009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended September 30, 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322093009.htm]
[] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharma Holdings, Inc., certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharma Holdings, Inc., certify that: 1) I have reviewed this quarterly report on Form 10-Q of China Pharma Holdings, Inc; 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2009 as filed with the Zhilin Li material respects, the financial condition and result of operations of the Company. Zhilin Li Chief Executive Officer EX-32.1 4 cph10qex321093009.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, In connection with the Quarterly Report of China Pharma Holdings, Inc. (the for the period ended September 30, 2009 as filed with the Frank Waung Chief Financial Officer EX-32.2 5 cph10qex322093009.htm]
[EXECUTION COPY 4,800,000 ORDINARY SHARES GOLDEN GREEN ENTERPRISES LIMITED UNDERWRITING AGREEMENT November 9, 2009 MAXIM GROUP LLC 405 Lexington Avenue New York, NY 10174 As Representative of the Underwriters Schedule A named on Ladies and Gentlemen: Company Underwriters Representative Ordinary Shares Firm Shares Golden Green Enterprises Limited, a corporation organized and existing under the laws of the British Virgin Islands] [No. 69 Huaibei Street Longhai Middle Road Zhengzhou, 451191, China x x Description 1.1 Underwriting Agreement, dated November 9, 2009 4.1 99.1]
[Home Inns Reports Third Quarter of 2009 Financial Results Quarterly Revenuesreased 38% Year-over-year to RMB 727 Million (US$ 107 Million); Shanghai, November9, 2009 Third Quarter 2009 Financial Highlights Total revenues for the quarterreased 37.9% year-over-year to RMB 727.4million (US$ 106.6million), exceeding guidance of RMB 685million to RMB 705million. Netome attributable to shareholders for the quarter]
[EXECUTION COPY 4,800,000 ORDINARY SHARES GOLDEN GREEN ENTERPRISES LIMITED UNDERWRITING AGREEMENT November 9, 2009 MAXIM GROUP LLC 405 Lexington Avenue New York, NY 10174 As Representative of the Underwriters Schedule A named on Ladies and Gentlemen: Company Underwriters Representative Ordinary Shares Firm Shares Golden Green Enterprises Limited, a corporation organized and existing under the laws of the British Virgin Islands] [No. 69 Huaibei Street Longhai Middle Road Zhengzhou, 451191, China x x Description 1.1 Underwriting Agreement, dated November 9, 2009 4.1 99.1]
[Home Inns Reports Third Quarter of 2009 Financial Results Quarterly Revenuesreased 38% Year-over-year to RMB 727 Million (US$ 107 Million); Shanghai, November9, 2009 Third Quarter 2009 Financial Highlights Total revenues for the quarterreased 37.9% year-over-year to RMB 727.4million (US$ 106.6million), exceeding guidance of RMB 685million to RMB 705million. Netome attributable to shareholders for the quarter]
[Registration Nos. 333-161924 and 333-163013 PROSPECTUS 4,800,000 Ordinary Shares GOLDEN GREEN ENTERPRISES LIMITED · We are offering 4,800,000 ordinary shares. · Our ordinary shares have been approved for listing on the Nasdaq Global Market under the symbol “CHOP.” The purchase of the ordinary shares involves a high degree of risk. See “ Risk Factors” beginning on e pag 10 .]
[China Pharmas, TABLE OFNTENTS Part I Financial Information 1 Item 1. Financial Statements 1ndensednsolidated Balance Sheets ofSeptember 30, 2009 and December 31, 2008 (Unaudited) 1ndensednsolidated Statements of Operations andmprehensiveome for the Three and Nine Months EndedSeptember 30, 2009 and 2008 (Unaudited)] [Certification of Chief Executive Officer I, Zhilin Li, the Chief Executive Officer of China Pharmas, certify that: 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [Certification of Chief Financial Officer I, Frank Waung, the Chief Financial Officer of China Pharmas, certify that: 1)I have reviewed this quarterly report on Form 10-Q of China Pharmas,; 2)Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the "Company") on Form 10-Q for the period ended September 30, 2009 filed with the Zhilin Li material respects, the financialndition and result of operations of thempany. Zhilin Li] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, Innnection with the Quarterly Report of China Pharmas, (the for the period ended September 30, 2009 filed with the Frank Waung Chief Financial Officer cph10qex322093009.htm 5 EX-32.2]
